CN113797293A - Anti-tumor traditional Chinese medicine composition and preparation method thereof - Google Patents
Anti-tumor traditional Chinese medicine composition and preparation method thereof Download PDFInfo
- Publication number
- CN113797293A CN113797293A CN202111281691.3A CN202111281691A CN113797293A CN 113797293 A CN113797293 A CN 113797293A CN 202111281691 A CN202111281691 A CN 202111281691A CN 113797293 A CN113797293 A CN 113797293A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- tumor
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anti-tumor traditional Chinese medicine composition and a preparation method thereof, wherein the anti-tumor traditional Chinese medicine composition comprises the following raw materials in parts by weight: 12-27 parts of cassia twig, 3-12 parts of edible tulip, 15-45 parts of poria cocos, 10-50 parts of liquorice, 10-40 parts of seaweed, 10-40 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 10-45 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 5-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia ternate. The feed also comprises the following raw materials in parts by weight: 60 parts of selfheal and 75 parts of spreading hedyotis herb. Also comprises a channel-inducing drug. Based on the difference of the affected parts of patients and the difference of clinical main symptoms, the treatment is carried out based on syndrome differentiation, and the channel-inducing drugs are added on the basis of the original prescription. The medicine is prepared into traditional Chinese medicine pills, is convenient to take and has good dosage; the common anti-tumor and cancer medicine can be prepared into main pills, and then different channels leading pills are matched according to different tumor-affected parts, so that the trouble of re-matching at different tumor-affected parts every time is avoided, and the medicine dispensing efficiency is improved; the medicine has high antitumor activity, no obvious toxic side effect and low medicine resistance.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to an anti-tumor traditional Chinese medicine composition and a preparation method thereof.
Background
Along with the change of living environment and living habits, the probability of suffering from tumor and cancer of modern people is higher and higher, the parts suffering from tumor and cancer are various, the toxicity of chemotherapy is high, the tumor cells are killed, and meanwhile, the human body autoimmune cells such as white blood cells and lymphocytes are not selectively killed, so that the autoimmune capacity of a patient is low and infection is caused, the adverse reaction of the patient is high, the pain degree of the patient is high, the treatment course is long, and the cost is high;
the traditional Chinese medicine has unique advantages in the aspect of treating tumors, and natural medicines represented by the traditional Chinese medicine have the characteristics of small toxic and side effects, various action targets, good tolerance and the like, and are increasingly emphasized in the aspect of treating tumors;
however, the traditional Chinese medicine needs to be decocted for oral administration, is troublesome to take, is difficult to master in dosage, and needs to be prepared from different traditional Chinese medicines according to different proportions aiming at different parts with tumor cancer, but some medicines for treating the tumor cancer are shared, and the proportioning is troublesome each time, so that the dispensing efficiency is influenced.
Disclosure of Invention
The technical problem to be solved by the invention is to overcome the existing defects and provide an anti-tumor traditional Chinese medicine composition and a preparation method thereof, which can effectively solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: an anti-tumor traditional Chinese medicine composition comprises the following raw materials in parts by weight: 12-27 parts of cassia twig, 3-12 parts of edible tulip, 15-45 parts of poria cocos, 10-50 parts of liquorice, 10-40 parts of seaweed, 10-40 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 10-45 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 5-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia ternate.
Further, the feed comprises the following raw materials in parts by weight: 12-20 parts of cassia twig, 3-10 parts of edible tulip, 20-45 parts of poria cocos, 20-50 parts of liquorice, 15-40 parts of seaweed, 12-30 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 12-40 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 6-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia ternate.
Further, the feed also comprises the following raw materials in parts by weight: 60 parts of selfheal and 75 parts of spreading hedyotis herb.
Furthermore, the medicine also comprises a guiding drug.
A preparation method of an anti-tumor Chinese medicinal composition comprises the following steps;
s1: adding 600 ml of water into 60 parts of selfheal and 75 parts of spreading hedyotis herb for one time, soaking for 40 minutes, decocting and collecting primary volatile oil, filtering decoction dregs and collecting primary liquid medicine, adding 400 ml of water into the remaining decoction dregs, decocting and collecting secondary volatile oil, filtering the decoction dregs and collecting secondary liquid medicine;
s2: mixing the primary liquid medicine and the secondary liquid medicine, filtering and concentrating to 350 ml of concentrated solution, mixing the concentrated solution with the primary volatile oil and the secondary volatile oil to form auxiliary liquid medicine, filling the auxiliary liquid medicine into a clean bottle, and sealing for later use;
s3: pulverizing ramulus Cinnamomi, Pseudobulbus Cremastrae seu pleiones, Poria, Glycyrrhrizae radix, Sargassum, radix scrophulariae, radix Ranunculi Ternati, Concha Ostreae, rhizoma Sparganii, radix aucklandiae, Bulbus Fritillariae Cirrhosae, and rhizoma Pinelliae into powder, decocting, concentrating into rice paste, drying in a 45 deg.C drier, and pulverizing the dried medicinal blocks into powder to obtain main medicinal powder;
s4: mixing with adjuvant liquid and main powder, and making into sorghum-sized main pill.
Further, grinding the channels-leading medicine into channel-leading medicine powder, mixing with adjuvant liquid, and making into sorghum-sized channel-leading pill.
Compared with the prior art, the invention has the beneficial effects that: the anti-tumor traditional Chinese medicine composition and the preparation method have the following advantages:
1. the medicine is prepared into traditional Chinese medicine pills, is convenient to take and has good dosage;
2. the common anti-tumor and cancer medicine can be prepared into main pills, and then different channels leading pills are matched according to different tumor-affected parts, so that the trouble of re-matching at different tumor-affected parts every time is avoided, and the medicine dispensing efficiency is improved;
3. the medicine has high antitumor activity, no obvious toxic side effect and low medicine resistance.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows: the embodiment provides a technical scheme: an anti-tumor traditional Chinese medicine composition comprises the following raw materials in parts by weight: 12-27 parts of cassia twig, 3-12 parts of edible tulip, 15-45 parts of poria cocos, 10-50 parts of liquorice, 10-40 parts of seaweed, 10-40 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 10-45 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 5-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia ternate.
The feed also comprises the following raw materials in parts by weight: 60 parts of selfheal and 75 parts of spreading hedyotis herb.
Also comprises a channel-inducing drug.
Wherein, the small amount is gradually increased to the adaptive amount in the initial period of the treatment administration.
Due to the difference of the height and the body weight of the individual, the dosage is increased or decreased.
Based on the difference of the affected parts of patients and the difference of clinical main symptoms, the treatment is carried out based on syndrome differentiation, and the channel-inducing drugs are added on the basis of the original prescription.
A preparation method of an anti-tumor Chinese medicinal composition comprises the following steps;
s1: adding 600 ml of water into 60 parts of selfheal and 75 parts of spreading hedyotis herb for one time, soaking for 40 minutes, decocting and collecting primary volatile oil, filtering decoction dregs and collecting primary liquid medicine, adding 400 ml of water into the remaining decoction dregs, decocting and collecting secondary volatile oil, filtering the decoction dregs and collecting secondary liquid medicine;
s2: mixing the primary liquid medicine and the secondary liquid medicine, filtering and concentrating to 350 ml of concentrated solution, mixing the concentrated solution with the primary volatile oil and the secondary volatile oil to form auxiliary liquid medicine, filling the auxiliary liquid medicine into a clean bottle, and sealing for later use;
s3: pulverizing 12-27 parts of cassia twig, 3-12 parts of edible tulip, 15-45 parts of poria cocos, 10-50 parts of liquorice, 10-40 parts of seaweed, 10-40 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 10-45 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 5-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia tuber into powder, decocting and concentrating the powder into rice paste, placing the rice paste in a 45-degree drying appliance to dry the rice paste into blocks, and pulverizing the dried medicine blocks into main medicine powder;
s4: mixing with adjuvant liquid and main powder, and making into sorghum-sized main pill.
Grinding the channels-leading medicine into channels-leading medicinal powder, mixing with adjuvant medicinal liquid, and making into channels-leading pill of sorghum size.
Example two: the preparation method of the anti-tumor traditional Chinese medicine composition in the embodiment is substantially the same as that of the anti-tumor traditional Chinese medicine composition in the first embodiment, except that the content of the raw materials of the anti-tumor traditional Chinese medicine composition is different;
an anti-tumor traditional Chinese medicine composition comprises the following raw materials in parts by weight: 12-20 parts of cassia twig, 3-10 parts of edible tulip, 20-45 parts of poria cocos, 20-50 parts of liquorice, 15-40 parts of seaweed, 12-30 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 12-40 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 6-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia ternate.
The feed also comprises the following raw materials in parts by weight: 60 parts of selfheal and 75 parts of spreading hedyotis herb.
Also comprises a channel-inducing drug.
Wherein, the small amount is gradually increased to the adaptive amount in the initial period of the treatment administration.
Due to the difference of the height and the body weight of the individual, the dosage is increased or decreased.
Based on the difference of the affected parts of patients and the difference of clinical main symptoms, the treatment is carried out based on syndrome differentiation, and the channel-inducing drugs are added on the basis of the original prescription.
Example three: this example is a further illustration of the drug of example one and example two:
for intracranial tumor cancer of head, patient with severe headache, the channels-guiding medicine is made up by using 10 portions of bupleurum root, 20 portions of ligusticum root, 15 portions of dahurian angelica root and 12 portions of ligusticum root through the processes of grinding 10 portions of bupleurum root, 20 portions of ligusticum root, 15 portions of dahurian angelica root and 12 portions of ligusticum root into powder, using auxiliary medicine liquor and channel-guiding medicinal powder as channel-guiding pill, for example, sorghum vulgare pers.
Instructions for administration: the channel guiding pill and the main medicine pill are taken simultaneously, 15 g of each pill is taken three times a day, and the pills are taken with warm boiled water for 70 days continuously.
Example four: this example is a further illustration of the drug of example one and example two:
for thyroid tumor, thyroid enlargement and thyroid gland side node roughness, the channels guiding medicine is 30 parts of kelp, 20 parts of airpotato yam rhizome and 10 parts of great burdock achene, 30 parts of kelp, 20 parts of airpotato yam rhizome and 10 parts of great burdock achene are ground into powder, and the auxiliary medicine liquid and the channel guiding medicine powder are mixed to form the channel guiding pill, such as sorghum vulgare.
Instructions for administration: the channel guiding pill and the main medicine pill are taken at the same time, 15 g of each pill is taken three times a day, and the pill is taken with warm boiled water for 60 days continuously.
Example five: this example is a further illustration of the drug of example one and example two:
for patients with esophageal cancer, gastric cancer and intestinal cancer, the channels guiding medicine is prepared from 3 parts of agilawood, 15 parts of cortex moutan, 12 parts of rheum officinale and 15 parts of coptis chinensis, the 3 parts of agilawood, 15 parts of cortex moutan, 12 parts of rheum officinale and 15 parts of coptis chinensis are ground into powder, and the auxiliary medicine liquid is used for mixing and guiding the channels into medicinal powder to form the channel guiding pills.
Instructions for administration: the pill for introducing channels and the pill for the upper main drug are taken at the same time, 15 g of each pill is taken three times a day, and the pill is taken with warm boiled water for 60 days continuously.
Example six: this example is a further illustration of the drug of example one and example two:
for patients with tongue gingival tumor cancer, the channels guiding medicine is prepared from 5 parts of asarum, 12 parts of baked ginger, 30 parts of hawthorn and 10 parts of bighead atractylodes rhizome, and the asarum, 12 parts of baked ginger, 30 parts of hawthorn and 10 parts of bighead atractylodes rhizome are ground into powder and mixed with the auxiliary medicine liquid to form the channel guiding pill.
Instructions for administration: the channel guiding pill and the upper main medicine pill are taken orally at the same time, 15 g of each pill is taken three times a day, and the pills are taken with warm boiled water. The medicine is taken continuously for 60 days.
Example seven: this example is a further illustration of the drug of example one and example two:
for lung cancer with tumor and rough nodule, 20 parts of coix seed and 10 parts of bighead atractylodes rhizome are used as menses guiding medicaments, 20 parts of coix seed and 10 parts of bighead atractylodes rhizome are ground into powder, and auxiliary medicinal liquid is used for mixing the powder of menses guiding medicaments to obtain the menses guiding pills.
Instructions for administration: the channel guiding pill and the upper main medicine pill are taken orally at the same time, 15 g of each pill is taken three times a day, and the pills are taken with warm boiled water for 70 days continuously.
Example eight: this example is a further illustration of the drug of example one and example two:
for hepatobiliary tumor cancer patients, the channels-inducing medicine is prepared from radix Paeoniae Rubra 15 parts, vinegar processed carapax Trionycis 30 parts, and bupleuri radix 12 parts, by grinding radix Paeoniae Rubra 15 parts, vinegar processed carapax Trionycis 30 parts, and bupleuri radix 12 parts into powder, and concocting with adjuvant liquid medicine to obtain channels-inducing pill.
Instructions for administration: the channel-inducing pill and the upper main medicine pill are taken orally at the same time, 20 g of each pill is taken three times a day, and the medicines are taken continuously for 100 days.
Example nine: this example is a further illustration of the drug of example one and example two:
for the tumor cancer of the internal and external bones of the spine, the channels guiding medicine is composed of 30 parts of dodder, 15 parts of drynaria rhizome and 20 parts of cibotium barometz, 30 parts of dodder, 15 parts of drynaria rhizome and 20 parts of cibotium barometz are ground into powder, and the auxiliary medicine liquid and the channel guiding medicine powder are used as channel guiding pills.
Instructions for administration: the channel guiding pill and the main medicine pill are taken orally at the same time, 20 g of each pill is taken three times a day, and the pills are taken with warm boiled water for 120 days continuously.
Example ten: this example is a further illustration of the drug of example one and example two:
for the tumor cancer of the bladder, cervix and annex of the small abdomen, the channel-guiding medicine is 20 parts of zedoary, 15 parts of vinegar rhizoma corydalis, 12 parts of motherwort and 15 parts of fried rhizoma cyperi, the 20 parts of zedoary, 15 parts of vinegar rhizoma corydalis, 12 parts of motherwort and 15 parts of fried rhizoma cyperi are ground into powder, and the auxiliary medicine liquid and the channel-guiding medicine powder are used as channel-guiding pills.
Instructions for administration: the channel guiding pill and the upper main medicine pill are taken orally at the same time, 15 g of each pill is taken three times a day, and the pills are taken with warm boiled water for 60 days continuously.
Example eleven: this example is a further illustration of the drug of example one and example two:
aiming at skin tumor cancer, sebaceous adenoma and lipoma, the channels-inducing medicine is prepared from 6-9 parts of ephedra herb, 7-12 parts of white mustard seed and 10-18 parts of deerhorn glue, 6-9 parts of ephedra herb, 7-12 parts of white mustard seed and 10-18 parts of deerhorn glue are ground into powder, and the auxiliary medicine liquid is used for adjusting and the channels-inducing medicine powder is used as the channel-inducing pill.
Instructions for administration: the channel guiding pill and the main medicine pill are taken orally at the same time, 15 g of each pill is taken three times a day, and the pills are taken with warm boiled water for 60 days continuously.
It should be noted that in the above examples, when rhinitis cancer and esophageal cancer are advanced, water and rice cannot be swallowed, and pills cannot be taken, a channel-leading pill for the case can be selected, 15 g of each main pill and 200 ml of warm boiled water are used for decocting, the temperature is kept, the medicine is retained for enema, the medicine is twice a day for half a month continuously, the tumor cancer can be reduced, millet filtrate can be added, and 70 days of continuous treatment can be achieved.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. An anti-tumor traditional Chinese medicine composition is characterized in that: the feed comprises the following raw materials in parts by weight: 12-27 parts of cassia twig, 3-12 parts of edible tulip, 15-45 parts of poria cocos, 10-50 parts of liquorice, 10-40 parts of seaweed, 10-40 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 10-45 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 5-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia ternate.
2. The anti-tumor traditional Chinese medicine composition according to claim 1, which is characterized in that: the feed comprises the following raw materials in parts by weight: 12-20 parts of cassia twig, 3-10 parts of edible tulip, 20-45 parts of poria cocos, 20-50 parts of liquorice, 15-40 parts of seaweed, 12-30 parts of radix scrophulariae, 10-40 parts of ternate buttercup root, 12-40 parts of oyster, 10-30 parts of rhizoma sparganii, 5-15 parts of elecampane, 6-15 parts of bulbus fritillariae cirrhosae and 5-30 parts of raw pinellia ternate.
3. The anti-tumor traditional Chinese medicine composition according to claim 2, which is characterized in that: the feed also comprises the following raw materials in parts by weight: 60 parts of selfheal and 75 parts of spreading hedyotis herb.
4. The anti-tumor traditional Chinese medicine composition according to claim 3, which is characterized in that: also comprises a channel-inducing drug.
5. The method for preparing a Chinese medicinal composition for treating tumor cancer according to any one of claims 1 to 4, wherein the method comprises the following steps: comprises the following steps;
s1: adding 600 ml of water into 60 parts of selfheal and 75 parts of spreading hedyotis herb for one time, soaking for 40 minutes, decocting and collecting primary volatile oil, filtering decoction dregs and collecting primary liquid medicine, adding 400 ml of water into the remaining decoction dregs, decocting and collecting secondary volatile oil, filtering the decoction dregs and collecting secondary liquid medicine;
s2: mixing the primary liquid medicine and the secondary liquid medicine, filtering and concentrating to 350 ml of concentrated solution, mixing the concentrated solution with the primary volatile oil and the secondary volatile oil to form auxiliary liquid medicine, filling the auxiliary liquid medicine into a clean bottle, and sealing for later use;
s3: pulverizing ramulus Cinnamomi, Pseudobulbus Cremastrae seu pleiones, Poria, Glycyrrhrizae radix, Sargassum, radix scrophulariae, radix Ranunculi Ternati, Concha Ostreae, rhizoma Sparganii, radix aucklandiae, Bulbus Fritillariae Cirrhosae, and rhizoma Pinelliae into powder, decocting, concentrating into rice paste, drying in a 45 deg.C drier, and pulverizing the dried medicinal blocks into powder to obtain main medicinal powder;
s4: mixing with adjuvant liquid and main powder, and making into sorghum-sized main pill.
6. The preparation method of the anti-tumor traditional Chinese medicine composition according to claim 5, which is characterized by comprising the following steps: grinding the channels-leading medicine into channels-leading medicinal powder, mixing with adjuvant medicinal liquid, and making into channels-leading pill of sorghum size.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111281691.3A CN113797293A (en) | 2021-11-01 | 2021-11-01 | Anti-tumor traditional Chinese medicine composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111281691.3A CN113797293A (en) | 2021-11-01 | 2021-11-01 | Anti-tumor traditional Chinese medicine composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113797293A true CN113797293A (en) | 2021-12-17 |
Family
ID=78898487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111281691.3A Pending CN113797293A (en) | 2021-11-01 | 2021-11-01 | Anti-tumor traditional Chinese medicine composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113797293A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104258295A (en) * | 2014-09-27 | 2015-01-07 | 王文玲 | Traditional Chinese medicine decoction for treating lymphoma |
| CN108404059A (en) * | 2018-05-31 | 2018-08-17 | 马海霞 | A kind of Chinese medicine composition for treating anti-type thyroid adenoma on liver-yang |
-
2021
- 2021-11-01 CN CN202111281691.3A patent/CN113797293A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104258295A (en) * | 2014-09-27 | 2015-01-07 | 王文玲 | Traditional Chinese medicine decoction for treating lymphoma |
| CN108404059A (en) * | 2018-05-31 | 2018-08-17 | 马海霞 | A kind of Chinese medicine composition for treating anti-type thyroid adenoma on liver-yang |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370687B (en) | A kind of compound Chinese medicinal preparation for treating colitis and preparation method thereof | |
| CN103251856B (en) | Traditional Chinese medicine preparation for benefiting Qi and nourishing blood and preparation method of traditional Chinese medicine preparation | |
| CN106390013A (en) | Compound traditional Chinese medicine composition capable of inhibiting colorectal liver metastases as well as preparation method and application thereof | |
| CN111658752A (en) | Medicine for treating diseases caused by novel coronavirus | |
| CN108186794B (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method and application thereof | |
| CN1056064C (en) | Medicine for curing liver cancer and its making method | |
| CN104771697A (en) | Pharacetuical composition for treating cholecystitis | |
| CN104436121B (en) | It is a kind of to treat irregular menstruation, small distention and fullness in the abdomen, the medicine to fail to be impregnated for a long time | |
| CN103830653A (en) | Pure traditional Chinese medicine preparation for treating infantile persistent diarrhea and preparation method thereof | |
| CN113797293A (en) | Anti-tumor traditional Chinese medicine composition and preparation method thereof | |
| CN1814217B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN104225016B (en) | A kind of pharmaceutical composition treating due to weakness of spleen and stomach chronic atrophic gastritis | |
| CN112891485A (en) | Traditional Chinese medicine composition for treating neocoronary pneumonia | |
| CN112717097A (en) | Traditional Chinese medicine composition for treating gastric cancer and preparation method thereof | |
| CN106511915A (en) | Applications of compound traditional Chinese medicinal composition in preparing medicines for inhibiting skin melanoma lung metastasis | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN101642485B (en) | Application of medical composition containing astragalus root in preparing medicine for treating leucopenia and Henoch-Schonlein Purpura | |
| CN102205031B (en) | Traditional Chinese medicine for treating male sterility | |
| CN115770279B (en) | Traditional Chinese medicine composition for treating chronic lower limb vein diseases, decoction and preparation thereof | |
| CN104189770A (en) | Pharmaceutical composition for treating tuberculous pleuritis and preparation method thereof | |
| CN108635498B (en) | Pharmaceutical composition for treating myelodysplastic syndrome and application thereof | |
| CN116350731B (en) | Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof | |
| CN108404059A (en) | A kind of Chinese medicine composition for treating anti-type thyroid adenoma on liver-yang | |
| CN115068575B (en) | Traditional Chinese medicine composition for treating recurrent oral ulcer | |
| CN115814020B (en) | Traditional Chinese medicine composition for treating ventricular arrhythmia and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211217 |
|
| RJ01 | Rejection of invention patent application after publication |